BIAFW vs HOLX · rev $6.2M vs P/E 32, rev $4.10B
bioAffinity Technologies Inc. Warrant (BIAFW) versus Hologic Inc (HOLX) — a side-by-side from cached financials, not a winner call.
bioAffinity Technologies Inc. Warrant (BIAFW) common stock listed on US.
Hologic Inc (HOLX) is a medical instruments & supplies company listed on NASDAQ.
Latest reported BIAFW revenue for 2025-12-31 was $6.2M. Net income was -$14.9M. Revenue was down 34.2% from 2024-12-31 to 2025-12-31. BIAFW currently screens at market cap $0.
Latest reported HOLX revenue for 2025-09-27 was $4.10B. Net income was $565.7M. Revenue was up 1.7% from 2024-09-28 to 2025-09-27. HOLX currently screens at market cap $16.97B and trailing P/E 31.5.
BIAFW currently screens at market cap $0. HOLX currently screens at market cap $16.97B and trailing P/E 31.5.
Not investment advice. Open the BIAFW and HOLX stock pages for the full models.
Not investment advice.